Immunological Enigma: A Case Report of COVID-19 Survival in a Patient With Human Immunodeficiency Virus, Hepatitis C Virus, and Tuberculosis Co-infection

This case report aims to elucidate the unique clinical course of a 34-year-old male patient diagnosed with human immunodeficiency virus (HIV), chronic hepatitis C, and prior tuberculosis (TB) infections, who subsequently contracted COVID-19. Immunological assessments revealed profound immunosuppression, marked by decreased CD4+ T cells (0.037 x 10⁹/L), alongside mildly elevated IgG levels (16.701 g/L), reflecting both HIV-related immunodeficiency and non-adherence to antiretroviral therapy (ART). Concurrently, the patient tested positive for SARS-CoV-2. Imaging findings demonstrated overlapping characteristics of TB and COVID-19. Timely initiation of specific TB therapy, alongside supportive care and optimized antiretroviral and anti-TB regimens, was implemented. Despite the patient's immunocompromised state and complex medical history, he successfully recovered from COVID-19. Key factors contributing to survival included early TB diagnosis and treatment, comprehensive medical care, careful management of drug interactions, and a potentially effective individual immune response. Notably, no typical features of COVID-19 pneumonia were observed, suggesting that the dual infection may have influenced the clinical presentation. This case underscores the potential for positive outcomes in individuals with complex medical histories, including coexisting infections. Further research into the interplay of multiple infections in such patients is warranted to optimize clinical management strategies and enhance our understanding of COVID-19 within this distinctive population.